Oncotarget

Research Papers:

Coronary computed tomographic angiography for patients with low-to-intermediate risk chest pain: A systematic review and meta-analysis

Yu Chen, Yuqi Fan, Zhaofang Yin, Huili Zhang, Yang Zhang, Zhihua Han and Changqian Wang _

PDF  |  HTML  |  How to cite

Oncotarget. 2017; 8:2096-2103. https://doi.org/10.18632/oncotarget.13782

Metrics: PDF 1716 views  |   HTML 2111 views  |   ?  


Abstract

Yu Chen1, Yuqi Fan1, Zhaofang Yin1, Huili Zhang1, Yang Zhang1, Zhihua Han1 and Changqian Wang1

1 Department of Cardiology, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Correspondence to:

Changqian Wang, email:

Keywords: coronary computed tomographic angiography, chest pain, coronary heart disease, functional test, meta-analysis

Received: August 26, 2016 Accepted: November 22, 2016 Published: December 02, 2016

Abstract

Coronary computed tomographic angiography (CCTA) can image the coronary vasculature rapidly and detect the presence and severity of luminal stenosis accurately. However, whether CCTA based care strategy could gain more benefits than conventional strategy with functional tests for patients with low-to-intermediate risk chest pain remains unknown. In this study we performed a meta-analysis to compare the clinical efficacy of CCTA versus conventional strategy. Eight randomized controlled trials with 14749 patients were finally included in this review after database searching. Compared with conventional strategy, CCTA significantly increased the rates of invasive coronary angiography (RR 1.44; 95% CI 1.28 to 1.63) and revascularization (RR 1.94; 95% CI 1.65 to 2.29), but did not change the rates of major adverse cardiovascular events (RR 1.10; 95% CI 0.92 to 1.30), death (RR 0.95; 95% CI 0.64 to 1.40) and hospital readmission (RR 0.96; 95% CI 0.66 to 1.40). Consequently, compared with conventional strategy, CCTA seemed not to improve clinical outcomes for patients with low-to-intermediate risk chest pain.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 13782